Appendix 4D - Condensed Financial Report 28 Febuary 2008
African Rainbow Minerals Limited (ARM), Anvil Mining Limited, Assmang Limited and Paladin Energy Limited Join Donor Syndicate for the Virax Southern Africa HIV Therapeutic Vaccine Project 27 Febuary 2008
Convertible Note Issue Raises $1.88 million 18 Febuary 2008
VIR201 Phase IIA Trial Results Now Published in Peer Reviewed Scientific Journal – Human Vaccines 6 Febuary 2008
Chairman’s Letter describing Fund Raising and the Corporate Strategy 30 January 2008
Technology License with Transgene: Product TG4010 Interim Results 24 January 2008
Appendix 3X & Appendix 3Z 22 January 2008
Convertible Note Issue - Amended Closing Date and Despatch Date 21 January 2008
Board Changes Completed and Extension of Rights Issue Closing Date 17 January 2008
Rights Issue Minimum Subscription Achieved 7 January 2008
Prospectus & Appointment of CEO 19 December 2007
Appendix 3B 19 December 2007
AGM Results 27 November 2007
Virax Fund Raising Proposed 27 November 2007
AGM Results and CEO Presentation 27 November 2007
Annual Report 21 September 2007
Virax Announces Grant of Key VIR201 Patent in Europe 19 September 2007
Virax Confirms Receipt of A$1m in Milestone Payments from Transgene 23 August 2007
